Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A question for the long timers.
Unless TPL agrees, they are buying nothing. Why would TPL want Scwartz as a partner verses a public company. What would they gain. Litigation from stock holders,,,,I don't think that would overule any other advantages. I am sure SEC investigations would follow, again more headaches. I wouldn't do it if I were TPL...would you?
Share
New Message
Please login to post a reply